Clinical Trial Update: Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Ocoxin-Viusid in advanced stomach cancer and related gastric/esophagogastric junction cancers has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive System Disease
• Digestive System Neoplasm
• Esophageal Disease
• Esophageal Neoplasm
• Esophagogastric Junction Disorder
• Gas Gastrointestinal Neoplasms
• Gastrointestinal Disease
• Head and Neck Neoplasm
• Stomach Disease
• Stomach Neoplasm

Drugs mentioned

• Ocoxin®-Viusid®

Snippet

Sponsor: Catalysis SL | Conditions: Stomach Neoplasm, Gastrointestinal Neoplasms | Phase 2 | Status: COMPLETED